Loading clinical trials...
Loading clinical trials...
Evaluating Potential Benefits of Intranasal Oxytocin on Undersea Operator Training and Performance: Hyperoxic Swim-Induced Oxidative Stress and Inflammation
Conditions
Interventions
Oxytocin nasal spray
Placebo nasal spray
Locations
3
United States
Translational Genomics Research Institute
Phoenix, Arizona, United States
University of Florida
Gainesville, Florida, United States
Florida Institute for Human and Machine Cognition
Pensacola, Florida, United States
Start Date
February 1, 2022
Primary Completion Date
September 15, 2023
Completion Date
September 15, 2023
Last Updated
February 22, 2024
NCT07547774
NCT07257029
NCT00397280
NCT04638647
NCT06200207
NCT06750653
Lead Sponsor
Florida Institute for Human and Machine Cognition
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions